AXSOME THERAPEUTICS, INC. Tax Withholding Paid on Stock Awards
AXSOME THERAPEUTICS, INC. (AXSM) reported Tax Withholding Paid on Stock Awards of $12.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-10
- AXSOME THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $2.83M, a 219.14% increase year-over-year.
- AXSOME THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $9.30M, a 114.51% increase year-over-year.
- AXSOME THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $1.04M, a 95.87% increase year-over-year.
- AXSOME THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $842.00K, a 78.01% increase year-over-year.
- AXSOME THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $7.11M, a 79.91% increase from fiscal 2024.
- AXSOME THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $3.95M, a 115.37% increase from fiscal 2023.
- AXSOME THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $1.83M, a 244.92% increase from fiscal 2022.
- AXSOME THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $532.00K, a 202.27% increase from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 3 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 12 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $12.13M 10-Q · filed 2026-08-10 | $13.18M derived: sum of 3 quarters · filed 2026-08-10 | $14.02M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $9.30M 10-Q · filed 2026-05-04 | $10.35M derived: sum of 2 quarters · filed 2026-05-04 | $11.19M derived: sum of 3 quarters · filed 2026-05-04 | $12.07M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.89M derived: sum of 2 quarters · filed 2026-02-23 | $2.77M derived: sum of 3 quarters · filed 2026-08-10 | $7.11M 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | $842.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $1.73M derived: sum of 2 quarters · filed 2026-08-10 | $6.07M 10-Q · filed 2025-11-03 | $6.60M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $888.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $5.22M 10-Q · filed 2026-08-10 | $5.76M derived: sum of 3 quarters · filed 2026-08-10 | $6.23M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $4.34M 10-Q · filed 2026-05-04 | $4.87M derived: sum of 2 quarters · filed 2026-05-04 | $5.34M derived: sum of 3 quarters · filed 2026-05-04 | $6.67M derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | $533.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.01M derived: sum of 2 quarters · filed 2026-02-23 | $2.33M derived: sum of 3 quarters · filed 2026-02-23 | $3.95M 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | $473.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $1.80M derived: sum of 2 quarters · filed 2025-11-03 | $3.42M 10-Q · filed 2025-11-03 | $3.70M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $2.95M 10-Q · filed 2025-08-04 | $3.23M derived: sum of 3 quarters · filed 2026-02-23 | $3.58M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | $1.62M 10-Q · filed 2025-05-05 | $1.90M derived: sum of 2 quarters · filed 2026-02-23 | $2.25M derived: sum of 3 quarters · filed 2026-02-23 | $2.59M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | $280.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $635.00K derived: sum of 2 quarters · filed 2026-02-23 | $968.00K derived: sum of 3 quarters · filed 2026-02-23 | $1.83M 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | $355.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $688.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.55M 10-Q · filed 2024-11-12 | $1.72M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | $333.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $1.20M 10-Q · filed 2024-08-05 | $1.36M derived: sum of 3 quarters · filed 2025-02-18 | $1.62M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | $867.00K 10-Q · filed 2024-05-06 | $1.03M derived: sum of 2 quarters · filed 2025-02-18 | $1.29M derived: sum of 3 quarters · filed 2025-02-18 | $1.31M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $424.00K derived: sum of 2 quarters · filed 2025-02-18 | $443.00K derived: sum of 3 quarters · filed 2025-02-18 | $532.00K 10-K · filed 2025-02-18 | $531.83K 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $261.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $280.00K derived: sum of 2 quarters · filed 2023-11-06 | $369.00K 10-Q · filed 2023-11-06 | $369.15K 10-Q · filed 2022-11-07 | $460.99K derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2022-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $108.00K 10-Q · filed 2023-08-07 | $107.52K 10-Q · filed 2022-08-09 | $199.99K derived: sum of 3 quarters · filed 2024-02-23 | $199.99K derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2022-03-31 | $89.00K 10-Q · filed 2023-05-09 | $88.59K 10-Q · filed 2022-05-02 | $180.99K derived: sum of 2 quarters · filed 2024-02-23 | $180.99K derived: sum of 3 quarters · filed 2024-02-23 | ||||
| 2021-12-31 | $91.99K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $91.99K derived: sum of 2 quarters · filed 2024-02-23 | $176.00K 10-K · filed 2024-02-23 | $175.71K 10-K · filed 2022-03-01 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $84.01K 10-Q · filed 2022-11-07 | ||||||
| 2021-06-30 | $84.01K 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |